- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Undervalued based on future growth
Indian Pharmaceuticals & Biotech Undervalued based on future growth
Results
5
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
5 companies
Strides Pharma Science
Market Cap: ₹60.2b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally.
STAR
₹653.45
7D
0.07%
1Y
-25.5%
Orchid Pharma
Market Cap: ₹41.0b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹808.55
7D
4.2%
1Y
-25.4%
Aarti Drugs
Market Cap: ₹32.2b
Through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.
524348
₹350.70
7D
-1.9%
1Y
-30.4%
Senores Pharmaceuticals
Market Cap: ₹23.8b
Develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally.
SENORES
₹517.05
7D
-5.9%
1Y
n/a
IOL Chemicals and Pharmaceuticals
Market Cap: ₹19.4b
Manufactures and sells pharmaceutical and chemical products in India and internationally.
524164
₹66.09
7D
-0.7%
1Y
-17.3%